Skip to content
Screener

Lifecore Biomedical, Inc. LFCR Q4 2027 earnings

Reported August 5, 2026 · Before market open

Revenue$34.2MIn line
EPS-$0.19In line
Revenue estimate$34.2M
EPS estimate-$0.19

Next report

Date not yet announced

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$156.71M-45.3%
Enterprise value$147.53M—
P/S1.3×—

FAQ

When did Lifecore Biomedical, Inc. report Q4 2027 earnings?
Lifecore Biomedical, Inc. (LFCR) reported Q4 2027 earnings on August 5, 2026 before market open.
What were Lifecore Biomedical, Inc.'s Q4 2027 revenue and EPS?
Lifecore Biomedical, Inc. reported revenue of $34.2M and eps of $-0.19 for Q4 2027.
Did Lifecore Biomedical, Inc. beat estimates in Q4 2027?
Revenue missed the consensus estimate of $34.2M by $10.2K. EPS beat the consensus estimate of $-0.19 by $0.00.
Where can I find Lifecore Biomedical, Inc.'s Q4 2027 SEC filings?
You can read the 8-K earnings release (0001005286-26-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.